A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Clinical trial NCT07737743 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07737743
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-27
- Primary completion
- 2029-02-19
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.